“…Otherwise, neutralizing antibodies and perhaps yet undefined factors in the plasma of some infected individuals inactivate HIV (892). Other procedures for increasing the detection of HIV in blood have included the measurement of p25 antigen (391) and HIV RNA by polymerase chain reaction (PCR) (480). However, the relation of these data to infectious particles, the potential source of transmission, is not clear.…”
Section: Hiv In Body Fluids and Its Reiation To Virus Transmissionmentioning
“…Otherwise, neutralizing antibodies and perhaps yet undefined factors in the plasma of some infected individuals inactivate HIV (892). Other procedures for increasing the detection of HIV in blood have included the measurement of p25 antigen (391) and HIV RNA by polymerase chain reaction (PCR) (480). However, the relation of these data to infectious particles, the potential source of transmission, is not clear.…”
Section: Hiv In Body Fluids and Its Reiation To Virus Transmissionmentioning
“…And, it may depend on many factors, including T-helper lymphocyte counts, T-suppressor cell counts, the presence or absence of HIV antigen, and the presence or absence of HIV antibody (30,31,47,62,84,89).…”
Section: Properties Of Heterosexual Transmissionmentioning
“…The test cannot detect these antigen-antibody complexes. Even with a complex dissociation technique, the sensitivity remains low and can only detect about 50% of asymptomatic patients (6). Following this, a p24 antigen detection method modified with a booster step was developed by introducing a signal amplification boosted system to overcome the problem (2,8,9,13,14).…”
We modified a p24 antigen enzyme-linked immunosorbent assay as a method for diagnosis and monitoring of human immunodeficiency virus type 1 (HIV-1) subtype E infection. This modified assay is based on the use of preheated immune complex dissociation combined with a booster step using a regular Vironostika HIV-1 p24 antigen assay (bioMerieux) to decrease the lower limit of p24 antigen detection from 10 pg/ml (lower limit achievable when using a regular p24 antigen assay) to 0.5 pg/ml (100 virions/ml) by the new method. The correlation between the values obtained by the HIV-1 RNA (Amplicor HIV-1 Monitor) assay and the p24 antigen assay modified with a booster step antigen assay in 160 frozen plasma samples with known viral load and 80 blind fresh plasma samples by Spearman rank were 0.671 (R 2 ؍ 0.450; P < 0.01) and 0.782 (R 2 ؍ 0.612; P < 0.01). During antiretroviral treatment, the change of p24 antigen level at >0.5 log correlated well with the level of HIV-1 in plasma. In order to improve the early diagnosis of HIV-1 infection in 121 infants born to HIV-1-infected mothers, a heat-denatured plasma p24 antigen assay modified with a booster step was compared with DNA-PCR and HIV RNA (nucleic acid sequence-based amplification) assays. The sensitivity of the antigen test modified with a booster step was similar to that of the HIV-1 RNA (NASBA QL) assay and better than that of the DNA-PCR assay (100 versus 61.90%) for subjects 1 to 2 months old. The overall results from this study might renew interest in p24 antigen detection as an easily affordable alternative method for diagnosis of HIV-1 infection and monitoring of disease progression in developing countries.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.